Designing melittin‐graphene hybrid complexes for enhanced antibacterial activity
X Lu, J Liu, L Gou, J Li, B Yuan… - Advanced healthcare …, 2019 - Wiley Online Library
Antimicrobial peptides (AMPs) promise a fundamental solution to the devastating threat of
drug‐resistant bacteria. However, drawbacks of AMPs (eg, poor cell membrane penetration …
drug‐resistant bacteria. However, drawbacks of AMPs (eg, poor cell membrane penetration …
Graphene oxide as antibacterial sensitizer: Mechanically disturbed cell membrane for enhanced poration efficiency of melittin
Natural antimicrobial peptides (AMPs) promise a fundamental solution to the devastating
threat of multidrug-resistant bacteria, while drawbacks such as limited antibacterial efficiency …
threat of multidrug-resistant bacteria, while drawbacks such as limited antibacterial efficiency …
Synthetic peptide (DP1) functionalized graphene oxide: A biocompatible nanoformulation with broad-spectrum antibacterial and antibiofilm activity
In the present scenario, clinical success of all existing antimicrobial regimes has been
severely challenged by bacterial infections and emergence of multidrug-resistant strains …
severely challenged by bacterial infections and emergence of multidrug-resistant strains …
Antibacterial and antibiofouling activities of antimicrobial peptide-functionalized graphene–silver nanocomposites for the inhibition and disruption of Staphylococcus …
T Parandhaman, P Choudhary… - ACS Biomaterials …, 2021 - ACS Publications
Owing to the emergence of antibiotic-resistant strains, bacterial infection and biofilm
formation are growing concerns in healthcare management. Herein, we report an eco …
formation are growing concerns in healthcare management. Herein, we report an eco …
Novel cyclic undecapeptides immobilized on reduced graphene oxide surface for enhanced antibacterial properties
The incorporation of antimicrobial peptides (AMPs) in graphene-based materials is a
growing strategy to overcome the shortcomings presented by conventional antimicrobial …
growing strategy to overcome the shortcomings presented by conventional antimicrobial …
Development of antibacterial peptides with efficient antibacterial activity, low toxicity, high membrane disruptive activity and a synergistic antibacterial effect
H Wang, M Niu, T Xue, L Ma, X Gu, G Wei… - Journal of Materials …, 2022 - pubs.rsc.org
The development of new antimicrobial drugs is urgently required to overcome bacterial
resistance which is a serious threat to human health. Antimicrobial peptides (AMPs) which …
resistance which is a serious threat to human health. Antimicrobial peptides (AMPs) which …
[HTML][HTML] A molecular architectural design that promises potent antimicrobial activity against multidrug-resistant pathogens
B Yuan, J Liu, Z Deng, L Wei, W Li, Y Dou, Z Chen… - NPG Asia …, 2021 - nature.com
Addressing the devastating threat of drug-resistant pathogens requires the discovery of new
antibiotics with advanced action mechanisms and/or novel strategies for drug design …
antibiotics with advanced action mechanisms and/or novel strategies for drug design …
Covalent functionalization of graphene sheets with different moieties and their effects on biological activities
The ongoing spread of multi-drug-resistant bacteria over the past few decades necessitates
collateral efforts to develop new classes of antibacterial agents with different mechanisms of …
collateral efforts to develop new classes of antibacterial agents with different mechanisms of …
Emerging trends and future direction of graphene family of materials as potential antimicrobials: A critical review
Graphene research has progressed at an unprecedented rate since 2004 when Novoselov
and Geim isolated and described a single sheet of graphene. In fact, the relentless progress …
and Geim isolated and described a single sheet of graphene. In fact, the relentless progress …
De Novo Designed Hexadecapeptides Synergize Glycopeptide Antibiotics Vancomycin and Teicoplanin against Pathogenic Klebsiella pneumoniae via Disruption of …
Given the worldwide prevalence of pathogenic drug-resistant bacteria and the slow pace of
new antibacterial development, discovering new uses for approved drugs that are outside …
new antibacterial development, discovering new uses for approved drugs that are outside …